Literature DB >> 21459278

Roles of mitochondrial benzodiazepine receptor in the heart.

Sirirat Surinkaew1, Siriporn Chattipakorn, Nipon Chattipakorn.   

Abstract

Mitochondrial benzodiazepine receptor (mBzR) is a type of peripheral benzodiazepine receptor that is located in the outer membrane of mitochondria. It is an 18-kDa protein that can form a multimeric complex with voltage-dependent anion channel (32 kDa) and adenine nucleotide translocator (30 kDa). mBzR is found in various species and abundantly distributed in peripheral tissues, including the cardiovascular system. The mitochondria are well known as the site of energy production, and the heart is the organ that highly requires this energy supply. In the past decades, it has been shown that mBzR plays a critical role in regulating mitochondrial and heart functions. A growing body of evidence demonstrates that mBzR is associated with regulation of mitochondrial respiration, mitochondrial membrane potential, apoptosis, and reactive oxygen species production. Moreover, mBzR has been suggested to play a role in alteration of physiological effects in the heart such as contractility and heart rate. mBzR is involved in the pathologic condition such as ischemia/reperfusion injury, responses to stress, and changes in electrophysiological properties and arrhythmogenesis. In this review, evidence of the roles of mBzR in the heart under both physiological and pathologic conditions is presented. Clinical studies regarding the use of pharmacologic intervention involving mBzR in the heart are also discussed as a possible target for the treatment of electrical and mechanical dysfunction in the heart.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459278     DOI: 10.1016/j.cjca.2010.12.023

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Biomarker and more: can translocator protein 18 kDa predict recovery from brain injury and myocarditis?

Authors:  DeLisa Fairweather; Tomás R Guilarte; Leslie T Cooper
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

2.  Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation.

Authors:  DeLisa Fairweather; Michael J Coronado; Amanda E Garton; Jennifer L Dziedzic; Adriana Bucek; Leslie T Cooper; Jessica E Brandt; Fatima S Alikhan; Haofan Wang; Christopher J Endres; Judy Choi; Martin G Pomper; Tomás R Guilarte
Journal:  J Cardiovasc Transl Res       Date:  2014-01-09       Impact factor: 4.132

Review 3.  TSPO: An Evolutionarily Conserved Protein with Elusive Functions.

Authors:  Frederick Bonsack; Sangeetha Sukumari-Ramesh
Journal:  Int J Mol Sci       Date:  2018-06-07       Impact factor: 5.923

Review 4.  Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.

Authors:  Xiaolong Qi; Jiahong Xu; Fei Wang; Junjie Xiao
Journal:  Oxid Med Cell Longev       Date:  2012-11-28       Impact factor: 6.543

5.  Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).

Authors:  Justina Šileikytė; Elizabeth Blachly-Dyson; Randall Sewell; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Fernanda Ricchelli; Paolo Bernardi; Michael Forte
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

6.  Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam.

Authors:  Dyfrig A Hughes
Journal:  Br J Pharmacol       Date:  2020-06-18       Impact factor: 9.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.